NanoString Technologies Inc (NASDAQ:NSTG) has been assigned a consensus rating of “Hold” from the seven analysts that are presently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating on the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $16.00.

Several analysts have recently commented on the company. Zacks Investment Research upgraded NanoString Technologies from a “sell” rating to a “hold” rating in a report on Wednesday, November 8th. Robert W. Baird cut their target price on NanoString Technologies from $14.00 to $12.00 and set an “outperform” rating on the stock in a research report on Friday, November 3rd. Finally, ValuEngine downgraded NanoString Technologies from a “sell” rating to a “strong sell” rating in a research report on Friday, February 2nd.

Shares of NanoString Technologies (NSTG) opened at $6.65 on Wednesday. NanoString Technologies has a twelve month low of $6.31 and a twelve month high of $20.70. The company has a current ratio of 3.35, a quick ratio of 2.89 and a debt-to-equity ratio of 1.08. The company has a market capitalization of $169.56, a price-to-earnings ratio of -3.21 and a beta of 0.78.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in NSTG. SG Americas Securities LLC acquired a new stake in NanoString Technologies during the 3rd quarter worth about $124,000. Tower Research Capital LLC TRC grew its position in NanoString Technologies by 1,050.2% during the 4th quarter. Tower Research Capital LLC TRC now owns 24,925 shares of the biotechnology company’s stock worth $186,000 after purchasing an additional 22,758 shares during the period. Trexquant Investment LP acquired a new stake in NanoString Technologies during the 3rd quarter worth about $203,000. Wells Fargo & Company MN grew its position in NanoString Technologies by 117.8% during the 4th quarter. Wells Fargo & Company MN now owns 27,224 shares of the biotechnology company’s stock worth $204,000 after purchasing an additional 14,724 shares during the period. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in NanoString Technologies during the 3rd quarter worth about $222,000. 91.97% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: This report was published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this report on another site, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this report can be viewed at https://theolympiareport.com/2018/02/14/nanostring-technologies-inc-nstg-given-consensus-rating-of-hold-by-brokerages.html.

NanoString Technologies Company Profile

NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.

Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.